Valuation: CellaVision AB

Market Cap 3.38B 349M 306M 285M 262M 492M 33.33B 500M 1.32B 16.53B 1.31B 1.28B 57.1B P/E 2026 *
24x
P/E 2027 * 19x
Enterprise Value 3.18B 328M 288M 268M 246M 462M 31.31B 470M 1.24B 15.53B 1.23B 1.2B 53.66B EV / Sales 2026 *
4.11x
EV / Sales 2027 * 3.61x
Free-Float
83.08%
Yield 2026 *
1.94%
Yield 2027 * 2.27%
1 day+2.61%
1 week-0.28%
Current month+6.02%
1 month+6.65%
3 months+14.24%
6 months-3.73%
Current year-8.14%
1 week 138.4
Extreme 138.4
146.4
1 month 131.8
Extreme 131.8
153
Current year 117.6
Extreme 117.6
166.8
1 year 117.6
Extreme 117.6
192.2
3 years 117.6
Extreme 117.6
302
5 years 117.6
Extreme 117.6
503.5
10 years 70.75
Extreme 70.75
503.5
Manager TitleAgeSince
Chief Executive Officer - 04/06/2026
Director of Finance/CFO 46 01/09/2025
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 62 03/05/2018
Chairman 64 28/04/2021
Date Insider Type Main position Quantity % Market Cap.
12/06/26 Buy 760 0.0032%
09/06/26 Buy

Director

314 0.0013%
09/06/26 Buy

Founder

33,000 0.1384%
Change 5-day change 1-year change 3-year change Capi.($)
+1.83%-0.28%-20.04%-34.81% 348M
+3.78%+2.39%+15.86%-39.35% 15.1B
+1.77%+9.42%+3.64%+97.22% 1.71B
+0.12%+3.20%-35.01%-80.54% 1.15B
+1.71%-2.42%-38.33%+13.14% 958M
+0.28%-1.20%-43.30%-53.77% 631M
+1.36%-1.22%-49.84%-57.38% 510M
+2.64%+4.85%+42.28%-51.24% 463M
+1.31%-0.32%-56.18%-60.88% 370M
-8.97%-13.36%+35.27% - 315M
Average +0.68%-2.54%-14.57%-29.73% 2.16B
Weighted average by Cap. +2.88%-6.96%+5.52%-29.62%

Financials

2026 *2027 *
Net sales 774M 79.84M 70.07M 65.25M 60.01M 112M 7.63B 114M 303M 3.78B 300M 293M 13.07B 870M 89.69M 78.71M 73.29M 67.41M 126M 8.57B 129M 340M 4.25B 337M 329M 14.68B
Net income 141M 14.56M 12.78M 11.9M 10.94M 20.51M 1.39B 20.86M 55.24M 690M 54.65M 53.47M 2.38B 178M 18.35M 16.1M 15M 13.79M 25.86M 1.75B 26.3M 69.64M 869M 68.89M 67.4M 3B
Net Debt -204M -21.07M -18.49M -17.22M -15.84M -29.69M -2.01B -30.2M -79.96M -998M -79.1M -77.39M -3.45B -242M -24.99M -21.93M -20.42M -18.78M -35.21M -2.39B -35.81M -94.83M -1.18B -93.81M -91.78M -4.09B
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
251
Date Price Change Volume
28/07/26 SEK 144.40 +1.83% 18,243
27/07/26 SEK 141.80 +1.29% 13,598
24/07/26 SEK 140.00 +0.72% 14,466
23/07/26 SEK 139.00 -2.25% 13,113
22/07/26 SEK 142.20 -1.80% 16,130
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
141.80SEK
Average target price
176.75SEK
Spread / Average Target
+24.65%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CEVI Stock